Hostname: page-component-6766d58669-r8qmj Total loading time: 0 Render date: 2026-05-19T13:15:59.073Z Has data issue: false hasContentIssue false

Seroepidemiological studies indicate frequent and repeated exposure to Campylobacter spp. during childhood

Published online by Cambridge University Press:  26 October 2010

C. W. ANG*
Affiliation:
Department of Medical Microbiology and Infection Control, VUMC Amsterdam, The Netherlands
P. F. M. TEUNIS
Affiliation:
Epidemiology and Surveillance Unit, Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA
P. HERBRINK
Affiliation:
Diagnostic Centre, SSDZ, Delft, The Netherlands
J. KEIJSER
Affiliation:
Diagnostic Centre, SSDZ, Delft, The Netherlands
Y. H. T. P. VAN DUYNHOVEN
Affiliation:
Laboratory for Zoonoses and Environmental Microbiology, Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands
C. E. VISSER
Affiliation:
Department of Medical Microbiology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
W. VAN PELT
Affiliation:
Epidemiology and Surveillance Unit, Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
*
*Author for correspondence: Dr C. W. Ang, Department of Medical Microbiology and Infection Control, VUMC Amsterdam, The Netherlands. (Email: w.ang@vumc.nl)
Rights & Permissions [Opens in a new window]

Summary

The annual number of episodes of clinical gastroenteritis caused by Campylobacter spp. in The Netherlands is estimated to be 75 000, i.e. once per 200 person life-years. This number is based on extrapolation of culture results from population-based studies. The number of culture-confirmed cases of Campylobacter infection peaks in the first 3 years of life and again between the ages of 20 and 25 years. The seroepidemiology of Campylobacter describes the relationship between age and exposure to Campylobacter and reflects both symptomatic and asymptomatic infections. Using a validated ELISA system, antibodies to Campylobacter were measured in an age-stratified sample (n=456) of the PIENTER serum collection of the Dutch general population. The seroprevalence of Campylobacter IgG antibodies increased with age, reaching almost 100% at age 20 years. Antibody levels steadily increased with age until young adulthood, suggesting repeated exposure to Campylobacter. In conclusion, seroepidemiological data demonstrated repeated exposures to Campylobacter throughout life, most of which do not lead to clinical symptoms. From young adulthood, >95% of the population in The Netherlands had serological evidence for exposure to Campylobacter.

Information

Type
Original Papers
Copyright
Copyright © Cambridge University Press 2010
Figure 0

Fig. 1. Specificity of Campylobacter IgG reactivity. Serum from seropositive individuals was incubated with bacterial suspensions before testing for IgG antibodies with C. jejuni as antigen source. (a) Anti-C. jejuni reactivity could be reduced by incubation with C. jejuni suspensions only, or (b) from suspensions with thermophilic Campylobacter spp., but not with suspensions of non-thermophilic Campylobacter spp., Helicobacter pylori or Legionella pneumophila. OD, Optical density.

Figure 1

Fig. 2. Levels of IgA, IgM and IgG anti-Campylobacter antibodies per age group. Anti-Campylobacter antibody levels are expressed as ratios.

Figure 2

Fig. 3. Frequency distribution of anti-Campylobacter IgG ratios in sera from different age groups and fitted components of binary mixture. (a–k) Distribution per age group. The line (—) in each figure indicates the distribution of the total group of sera, whereas the histograms indicate the distribution of each component. In (a), all individuals are in the component with lower IgG level (‘seronegative’) and in each consecutive panel, the number of individuals in the component with the higher IgG level (‘seropositive’) increases. (l) Estimated prevalence (number ‘seropositive’) for each age group.

Figure 3

Fig. 4. Estimated levels of anti-Campylobacter IgG per age group according to sex, compared with culture-based relative incidence. The estimated age distribution of laboratory-confirmed Campylobacter infections in The Netherlands (2003–2006) is plotted for males and females for an average degree of urbanization. The 90% confidence interval is very small and has been omitted. Similarly the fitted average levels have been plotted for the IgG ratio. For the IgG ratio only the age trajectories were plotted that comprise significant differences between males and females, i.e. where the 90% CI (not plotted) did not overlap (12–20 years and 28–40 years).